IPO registrations (S-1, F-1) · Underwriters
Lynch &
- Deals
- 10 priced offerings as an underwriter; 10 initial public offerings
- Proceeds of those deals
- $1,980,399,847
- Years
- 2003–2007
- Named in
- 19 prospectuses and registration statements in all, including offerings not yet priced or withdrawn
- Named as
- Lynch &; Lynch & Co
Deals by year
| Year | Deals | As lead | Proceeds of deals |
|---|---|---|---|
| 2007 | 7 | 0 | $1,288,699,847 |
| 2006 | 1 | 0 | $137,500,000 |
| 2005 | 1 | 0 | $79,200,000 |
| 2003 | 1 | 0 | $475,000,000 |
Deals 10
| Priced | Company | Role | Price | Range | Shares | Proceeds | Listing | Kind | Syndicate | Prospectus |
|---|---|---|---|---|---|---|---|---|---|---|
| 2007-09-20 | ATHENAHEALTH INC MA | Syndicate | $18.00 | 6,286,819 | $113,162,742 | Nasdaq ATHN | IPO | 6 | 424B4 ↗ | |
| 2007-08-02 | Dolan Co. MN | Syndicate | $14.50 | 13,456,522 | $195,119,569 | NYSE DM | IPO | 6 | 424B4 ↗ | |
| 2007-07-27 | lululemon athletica inc. A1 | Syndicate | $18.00 | 18,200,000 | $327,600,000 | Nasdaq LULU | IPO | 13 | 424B4 ↗ | |
| 2007-07-27 | Voltaire Ltd. L3 | Syndicate | $9.00 | 5,770,000 | $51,930,000 | Nasdaq VOLT | IPO | 5 | 424B1 ↗ | |
| 2007-07-26 | VALIDUS HOLDINGS LTD D0 | Syndicate | $22.00 | 15,244,888 | $335,387,536 | NYSE VR | IPO | 24 | 424B4 ↗ | |
| 2007-05-15 | INSULET CORP MA | Syndicate | $15.00 | 7,700,000 | $115,500,000 | Nasdaq PODD | IPO | 7 | 424B4 ↗ | |
| 2007-04-18 | MBF Healthcare Acquisition Corp. FL | Syndicate | $8.00 | 18,750,000 | $150,000,000 | NYSE American MBH.U | IPO | 7 | 424B4 ↗ | |
| 2006-10-13 | ULTRAPETROL BAHAMAS LTD C5 | Syndicate | $11.00 | 12,500,000 | $137,500,000 | IPO | 7 | 424B1 ↗ | ||
| 2005-03-04 | Aspreva Pharmaceuticals CORP A1 | Syndicate | $11.00 | 7,200,000 | $79,200,000 | Nasdaq ASPV | IPO | 5 | 424B4 ↗ | |
| 2003-10-31 | OVERNITE CORP VA | Syndicate | $19.00 | 25,000,000 | $475,000,000 | Nasdaq OVNT | IPO | 7 | 424B4 ↗ |
“Offering” is a priced registered offering that the cover page does not describe as an initial public offering: a follow-on, a resale, or a small company’s best-efforts deal.
Works alongside
| Firm | Deals together | Of which that firm led |
|---|---|---|
| Merrill Lynch | 10 | 7 |
| J.P. Morgan | 5 | 3 |
| Goldman Sachs | 4 | 3 |
| Sachs & Co | 4 | 0 |
| Thomas Weisel Partners | 3 | 0 |
| UBS | 3 | 1 |
| BofA Securities | 2 | 0 |
| Credit Suisse | 2 | 1 |
| Jefferies | 2 | 1 |
| Piper Sandler | 2 | 1 |
| Wachovia | 2 | 0 |
| Weisel Partners LLC | 2 | 0 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Offering terms are read from the cover pages of the registrant's final prospectus (424B4, 424B1) and its latest registration statement before pricing: the price range, the final price, shares offered, gross proceeds (the cover's total, else price times shares), exchange and ticker, and the underwriters named on the cover and in the underwriting table (loader/s1_terms.py). Underwriter names are normalised, so Goldman, Sachs & Co. of 1999 and Goldman Sachs & Co. LLC of 2024 are one firm.